causaLens, a member of the World Economic Forum’s Global Innovators community, uses causality to introduce more nuance, reasoning and cause-and-effect sensibility into enterprise AI-decision making. The UK scale-up says its approach will allow enterprises to start creating solutions that can be used for their most critical tasks, including decisions that have a strong impact on their customers and broader society. BMW Group, Aviva and ScotiaBank are customers.
In healthcare, causaLens says its approach has accelerated discovery of protein biomarkers as a predictor for cancer by 100x. And in business, it says sophisticated marketing departments use its algorithms to identify the true drivers of customer behavior.
This article is part of The Innovator’s premium content and available only to The Innovator’s Radar subscribers.
If you are already a Radar subscriber click here to sign into your account
